The number of ordering physicians increased by 89% in Q3 2026 compared to Q3 2025. Physicians who ordered CyPath Lung through Q3 2025 continued to expand utilization of the test, with sales volume ...

The possibility of having a tool that facilitates population screening for Chronic Obstructive Pulmonary Disease (COPD) is getting closer. A multicenter study involving leading hospitals across Spain, ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease (COPD), are the fifth-leading cause of death in the United States. A contributing factor is diagnostic ...

Risk assessment Risk factors include history of exposure to cigarette smoke or heating fuels; occupational exposure to toxins, dusts, or industrial chemicals; exposure to environmental pollution, such ...

Please provide your email address to receive an email when new articles are posted on . Risk for COPD, respiratory-related mortality and a respiratory exacerbation could be found via blood test. More ...

Affinity Technologies (NASDAQ:BIAF) will present new clinical findings on its noninvasive lung cancer test, CyPath® Lung, at the 2026 NAVREF Annual Conference, running September 27–30 in Arlington, ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced a significant ...

Intellectual property arising from the collaboration related to the asthma and COPD testing platform will be owned by bioAffinity Technologies. Credit: Jo Panuwat D / Shutterstock.com. · Hospital ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Researchers have identified biomarkers that can be detected in a simple urine test and then, using an AI algorithm, predicted when COPD symptoms will flare up. The team, which included researchers ...

Lung cancer kills more people worldwide than any other malignancy, and the reason is painfully simple: it is usually caught ...